$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000114519717000017 Filed on November 03, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$130.5M	$121.8M	$94.87M
YoY Change	26.02%	28.36%	32.89%
Cost Of Revenue	$51.00M	$48.15M	$39.23M
YoY Change	19.72%	22.74%	-1.49%
Gross Profit	$79.51M	$73.62M	$55.64M
YoY Change	30.48%	32.32%	76.25%
Gross Profit Margin	60.91%	60.46%	58.65%
Selling, General & Admin	$61.50M	$51.44M	$39.49M
YoY Change	25.51%	30.25%	8.7%
% of Gross Profit	77.35%	69.86%	70.97%
Research & Development	$18.80M	$20.14M	$13.73M
YoY Change	17.5%	46.65%	36.86%
% of Gross Profit	23.65%	27.36%	24.68%
Depreciation & Amortization	$3.320M	$3.820M	$3.620M
YoY Change	-1.19%	5.52%	-15.81%
% of Gross Profit	4.18%	5.19%	6.51%
Operating Expenses	$80.30M	$71.58M	$53.22M
YoY Change	23.35%	34.49%	14.79%
Operating Profit	-$768.0K	$2.047M	$2.418M
YoY Change	-81.43%	-15.34%	-116.34%
Interest Expense	-$5.500M	-$4.200M	-$2.800M
YoY Change	-15.38%	50.0%	-9.68%
% of Operating Profit		-205.18%	-115.8%
Other Income/Expense, Net		-$4.153M	-$5.369M
YoY Change		-22.65%	70.66%
Pretax Income	-$6.900M	-$2.106M	-$2.951M
YoY Change	-23.33%	-28.63%	-83.55%
Income Tax	-$400.0K	$100.0K	$100.0K
% Of Pretax Income
Net Earnings	-$6.860M	-$2.227M	-$3.081M
YoY Change	-24.77%	-27.72%	-83.72%
Net Earnings / Revenue	-5.26%	-1.83%	-3.25%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share	-$118.6K	-$0.04	-$54.10K
COMMON SHARES
Basic Shares Outstanding	58.19M shares	58.10M shares	57.27M shares
Diluted Shares Outstanding		58.10M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$440.1M	$275.8M	$282.7M
YoY Change	47.39%	-2.44%	94.3%
Cash & Equivalents	$272.6M	$102.2M	$215.4M
Short-Term Investments	$167.5M	$173.5M	$67.30M
Other Short-Term Assets	$9.900M	$8.000M	$7.900M
YoY Change	39.44%	1.27%	97.5%
Inventory	$33.79M	$35.05M	$32.66M
Prepaid Expenses	$9.949M
Receivables	$53.37M	$47.17M	$38.55M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$537.2M	$366.0M	$361.8M
YoY Change	45.2%	1.16%	86.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.9M	$88.49M	$50.91M
YoY Change	141.02%	73.82%	22.57%
Goodwill	$39.80M	$39.85M	$39.73M
YoY Change	0.31%	0.31%	1553.35%
Intangibles	$4.351M
YoY Change
Long-Term Investments	$125.5M
YoY Change
Other Assets	$1.969M	$1.614M	$98.00K
YoY Change	811.57%	1546.94%	-97.76%
Total Long-Term Assets	$279.6M	$134.3M	$91.39M
YoY Change	222.51%	46.98%	-7.48%
TOTAL ASSETS
Total Short-Term Assets	$537.2M	$366.0M	$361.8M
Total Long-Term Assets	$279.6M	$134.3M	$91.39M
Total Assets	$816.7M	$500.3M	$453.2M
YoY Change	78.86%	10.4%	54.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.41M	$28.65M	$18.21M
YoY Change	85.51%	57.3%	16.64%
Accrued Expenses	$59.26M	$44.90M	$33.73M
YoY Change	43.73%	33.1%	-5.11%
Deferred Revenue	$2.356M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00		$1.100M
YoY Change	-100.0%		-81.67%
Total Short-Term Liabilities	$86.03M	$74.94M	$54.25M
YoY Change	54.45%	38.13%	-8.72%
LONG-TERM LIABILITIES
Long-Term Debt	$566.2M	$345.0M	$329.0M
YoY Change	70.14%	4.86%	89.2%
Other Long-Term Liabilities	$6.030M	$6.201M	$4.888M
YoY Change	19.83%	26.86%	35.06%
Total Long-Term Liabilities	$572.2M	$351.2M	$333.9M
YoY Change	69.39%	5.18%	88.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$86.03M	$74.94M	$54.25M
Total Long-Term Liabilities	$572.2M	$351.2M	$333.9M
Total Liabilities	$658.2M	$426.1M	$388.1M
YoY Change	67.28%	9.79%	63.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$707.3M	-$700.4M	-$671.3M
YoY Change	3.94%	4.33%	7.54%
Common Stock	$58.00K	$58.00K	$57.00K
YoY Change	1.75%	1.75%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.5M	$74.25M	$65.10M
YoY Change
Total Liabilities & Shareholders Equity	$816.7M	$500.3M	$453.2M
YoY Change	78.86%	10.4%	54.61%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$6.860M	-$2.227M	-$3.081M
YoY Change	-24.77%	-27.72%	-83.72%
Depreciation, Depletion And Amortization	$3.320M	$3.820M	$3.620M
YoY Change	-1.19%	5.52%	-15.81%
Cash From Operating Activities	$21.80M	$23.28M	$2.680M
YoY Change	8.62%	768.66%	-69.34%
INVESTING ACTIVITIES
Capital Expenditures	-$29.42M	-$8.740M	-$13.30M
YoY Change	911.0%	-34.29%	425.69%
Acquisitions
YoY Change
Other Investing Activities	-$119.9M	$11.53M	-$31.74M
YoY Change	27.17%	-136.33%	572.46%
Cash From Investing Activities	-$149.3M	$2.780M	-$45.04M
YoY Change	53.64%	-106.17%	522.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	297.9M	2.460M	182.2M
YoY Change	-30190.91%	-98.65%	-19073.96%
NET CHANGE
Cash From Operating Activities	21.80M	23.28M	2.680M
Cash From Investing Activities	-149.3M	2.780M	-45.04M
Cash From Financing Activities	297.9M	2.460M	182.2M
Net Change In Cash	170.4M	28.52M	139.8M
YoY Change	-318.17%	-79.6%	25787.04%
FREE CASH FLOW
Cash From Operating Activities	$21.80M	$23.28M	$2.680M
Capital Expenditures	-$29.42M	-$8.740M	-$13.30M
Free Cash Flow	$51.22M	$32.02M	$15.98M
YoY Change	122.89%	100.38%	41.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58187756	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	INSULET CORP
	dei	Trading Symbol TradingSymbol	PODD
CY2016Q3	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	1041000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	3054000	USD
CY2017Q3	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	1449000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	4276000	USD
CY2017Q3	podd	Finite Lived Intangible Assets Amortization Expense Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseThereafter	331000	USD
CY2017Q3	podd	Finited Lived Intangible Assets Excluding Software In Process Of Development Net FinitedLivedIntangibleAssetsExcludingSoftwareInProcessOfDevelopmentNet	4369000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-632000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	10502000	USD
CY2016Q3	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	5715000	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	11720000	USD
CY2017Q3	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	5566000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	16461000	USD
CY2017Q3	podd	Number Of Financial Institution NumberOfFinancialInstitution	1	location
CY2017Q3	podd	Number Of Inches Of Tubing In Conventional Insulin Pump NumberOfInchesOfTubingInConventionalInsulinPump	42	in
	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.16
	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.21
	podd	Return Period ReturnPeriod	P45D
	podd	Return Period Canada ReturnPeriodCanada	P90D
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	41228000	USD
CY2017Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44897000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13160000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	28648000	USD
CY2016Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2886000	USD
CY2017Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	932000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	31714000	USD
CY2017Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	50210000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28803000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47173000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41228000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44897000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6753000	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8972000	USD
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	21999000	USD
CY2017Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	27389000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39000000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-726000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-123000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y10M10D
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	744243000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	774714000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6088000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16873000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8897000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23552000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2911000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3037000	USD
CY2016Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1901000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5330000	USD
CY2017Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3612000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10690000	USD
CY2016Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	222000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	785000	USD
CY2017Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	505000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1495000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6117000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12185000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11867137	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11850509	shares
CY2016Q4	us-gaap	Assets Assets	456647000	USD
CY2017Q3	us-gaap	Assets Assets	500348000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	369960000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	366020000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	161396000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	173523000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	207000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	199000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	161603000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	173721000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	161396000	USD
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	173523000	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2000000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10700000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122672000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215402000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	137174000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102233000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	92730000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-34941000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	2000000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57457967	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58156128	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57457967	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58156128	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	57000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3226000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19493000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-982000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1822000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19368000	USD
CY2016Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39230000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	113265000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	48151000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	135583000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	69684000	USD
CY2017Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	58994000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	9632000	USD
CY2017Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	8137000	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	1900000	USD
CY2017Q3	us-gaap	Deferred Revenue DeferredRevenue	2600000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1309000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1395000	USD
CY2016Q3	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	0	USD
	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	100000	USD
CY2017Q3	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	0	USD
	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10474000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10533000	USD
CY2016Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	-0.03
CY2017Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
CY2016Q3	us-gaap	Discontinued Operation Intra Entity Amounts Discontinued Operation After Disposal Expense DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense	100000	USD
	us-gaap	Discontinued Operation Intra Entity Amounts Discontinued Operation After Disposal Expense DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense	800000	USD
CY2017Q3	us-gaap	Discontinued Operation Intra Entity Amounts Discontinued Operation After Disposal Expense DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense	0	USD
	us-gaap	Discontinued Operation Intra Entity Amounts Discontinued Operation After Disposal Expense DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense	0	USD
	us-gaap	Discontinued Operation Period Of Continuing Involvement After Disposal DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal	P0Y6M0D
CY2016Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	408000	USD
CY2017Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	158000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	487000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	48774000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4017000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4955000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1330000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	390000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	578000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	727000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1013000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6058000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9324000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2041000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	537000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2551000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4369000	USD
CY2016Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2551000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17342000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47923000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22718000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	62322000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	39677000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	39854000	USD
CY2016Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	55641000	USD
	us-gaap	Gross Profit GrossProfit	150149000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	73624000	USD
	us-gaap	Gross Profit GrossProfit	197661000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2951000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17862000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2106000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19653000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3017000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-18057000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2227000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19971000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.05
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.32
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.04
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.34
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-64000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1703000	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	121000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	318000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2839000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3816000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2994000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19757000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21287000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-428000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	756000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	668000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3268000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1290000	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3029000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	9252000	USD
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	4709000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	14512000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17922000	USD
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17597000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	35514000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	35054000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1911000	USD
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2289000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	15681000	USD
CY2017Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	15168000	USD
CY2016Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1900000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2100000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	393497000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	426094000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	456647000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	500348000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	55697000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	74940000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	332768000	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	344953000	USD
CY2015Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	400000	USD
CY2016Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	300000	USD
CY2015Q2	us-gaap	Loss Contingency Claims Dismissed Number LossContingencyClaimsDismissedNumber	2	LegalMatter
CY2017Q3	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	300000	USD
CY2015Q2	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	LegalMatter
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	177558000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6650000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-80827000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61485000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4159000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19407000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-3081000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19760000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2227000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19971000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4848000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	269000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	44969000	USD
CY2017Q3	us-gaap	Noncurrent Assets NoncurrentAssets	88622000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5369000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11293000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4153000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13034000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	53223000	USD
	us-gaap	Operating Expenses OperatingExpenses	156718000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	71577000	USD
	us-gaap	Operating Expenses OperatingExpenses	204280000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2418000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6569000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2047000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6619000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	13024000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2702000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	2383000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	2402000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	2681000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2131000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	725000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7948000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6021000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	216000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1614000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-102000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	302000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	329000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	594000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-145000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	267000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	405000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	603000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-43000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-35000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	76000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5032000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6201000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	211000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	510000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	556000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1478000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	139000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	519000	USD
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	76241000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	115056000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19205000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47813000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7073000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8037000	USD
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	5714000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10735000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	333904000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	8905000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	101384000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4152000	USD
CY2016Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4294000	USD
CY2016Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4342000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4388000	USD
CY2017Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4817000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4997000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1642000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1583000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	2746000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3414000	USD
CY2016Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1101000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3098000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1303000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2514000	USD
CY2016Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1149000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3288000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1483000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3123000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44753000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	88491000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1889000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1502000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	153628000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	4727000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1200000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13734000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39676000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20141000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55670000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	500000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-680424000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-700395000	USD
CY2016Q3	us-gaap	Revenues Revenues	94871000	USD
	us-gaap	Revenues Revenues	263414000	USD
CY2017Q3	us-gaap	Revenues Revenues	121775000	USD
	us-gaap	Revenues Revenues	333244000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	94871000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	263414000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	121775000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	333244000	USD
CY2016Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22147000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69119000	USD
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28718000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	86288000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16850000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23551000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5100000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1860596	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	33.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7696000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	85796	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	519231	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	70718000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3441303	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3489393	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.27
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.82
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	67057000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3282803.92	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	26.11
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	34.82
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	45.23
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	40326000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M10D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M14D
CY2016Q3	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1100000	USD
	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	2800000	USD
CY2017Q3	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1300000	USD
	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	3500000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	385345	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	63150000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	74254000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57341000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57189000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58100000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57925000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Nature of the Business </font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Insulet Corporation, the "Company," is primarily engaged in the development, manufacturing and sale of its proprietary Omnipod Insulin Management System (“Omnipod System”), an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a small, lightweight, self-adhesive disposable tubeless Omnipod device which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager ("PDM"). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to </font><font style="font-family:Arial;font-size:10pt;">42</font><font style="font-family:Arial;font-size:10pt;"> inches of tubing. In contrast, the Omnipod System features only two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Company believes that the Omnipod System’s unique proprietary design and features allow people with insulin-dependent diabetes to manage their diabetes with unprecedented freedom, comfort, convenience, and ease. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial sales of the Omnipod System began in the United States in 2005. The Company sells the Omnipod System in the United States through direct sales to customers or through its distribution partners. The Omnipod System is currently available in multiple countries in Europe, as well as in Canada and Israel. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The Company announced on July 20, 2017 its plans to assume, on July 1, 2018, the distribution, sales, marketing, training and support activities of its Omnipod System across Europe following the expiration of its global distribution agreement with Ypsomed Distribution AG ("Ypsomed') on June 30, 2018. Until the expiration of the agreement, Ypsomed will remain the distributor of the Company's Omnipod products in Europe. The Company will be required to pay to Ypsomed a per unit fee for direct sales over the 12 month period following the expiration of the global distribution agreement of its Omnipod device to former customers of Ypsomed, as defined in the distribution agreement. The Company will recognize a liability for this fee as it sells its Omnipod device to these customers during the twelve-month period beginning July 1, 2018. </font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In addition to using the Omnipod System for insulin delivery, the Company also partners with global pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas.</font></div><div style="line-height:120%;padding-top:12px;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, “Neighborhood Diabetes”) in </font><font style="font-family:Arial;font-size:10pt;">June 2011</font><font style="font-family:Arial;font-size:10pt;">. Through Neighborhood Diabetes, the Company provided customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and had the ability to process claims as either durable medical equipment or through pharmacy benefits. In February 2016, the Company sold Neighborhood Diabetes to Liberty Medical LLC ("Liberty Medical"). Additional information regarding the disposition and treatment of the Neighborhood Diabetes business as discontinued operations is provided in Note </font><font style="font-family:Arial;font-size:10pt;">3</font><font style="font-family:Arial;font-size:10pt;"> to these consolidated financial statements.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification of Prior Period Balances</font></div><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation including the reclassification of capitalized internal-use software costs from property and equipment to other intangible assets for the year ended December 31, 2016 upon adoption of Accounting Standards Update ("ASU") 2016-19, </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Technical Corrections and Improvements</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in the application of certain of its significant accounting policies that may materially affect the reported amounts of assets, liabilities, equity, revenue and expenses. The most significant estimates used in these financial statements include the valuation of stock-based compensation expense; the fair value of intangible assets acquired in businesses combinations; the valuation of inventory; the fair value of reporting units used to calculate the potential impairment of goodwill; the valuation of deferred revenue; the calculation of gains and losses, if any, on the retirement or conversion of convertible debt; the estimated useful lives of property and equipment and intangible assets; the amount of internal use software development costs that qualify for capitalization; the estimated amount, if any, of accrued contingent liabilities as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001145197-17-000017-index-headers.html	Edgar Link	pending
0001145197-17-000017-index.html	Edgar Link	pending
0001145197-17-000017.txt	Edgar Link	pending
0001145197-17-000017-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
podd-20170930.xml	Edgar Link	completed
podd-20170930.xsd	Edgar Link	pending
podd-20170930_cal.xml	Edgar Link	unprocessable
podd-20170930_def.xml	Edgar Link	unprocessable
podd-20170930_lab.xml	Edgar Link	unprocessable
podd-20170930_pre.xml	Edgar Link	unprocessable
podd-2017x09x30_10q.htm	Edgar Link	pending
podd-exx101_20170930x10q.htm	Edgar Link	pending
podd-exx311_20170930x10q.htm	Edgar Link	pending
podd-exx312_20170930x10q.htm	Edgar Link	pending
podd-exx321_20170930x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2017 Q4 Form 10-Q Financial Statement

#000114519717000017 Filed on November 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2017 Q4 Form 10-Q Financial Statement

#000114519717000017 Filed on November 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd